In August, the FDA's Reproductive Health Drugs Advisory Committee backed two treatment indications for denosumab (for bone loss in postmenopausal osteoporosis and in hormone ablation therapy for ...
Bisphosphonates are currently the medication of choice for both prevention and treatment of glucocorticoid-induced osteoporosis. Teriparatide has been shown to be better than alendronate and might ...
The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...
Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...
Osteoporosis is a disabling skeletal disorder that is characterized by decreased bone strength, predisposing patients to increased risk of bone fracture. Peak bone mass (maximum bone strength and ...
Most conventional anti-osteoporosis medications are contraindicated in CKD patients because they may worsen renal function. Therefore, there was urgent need to develop safe and effective drugs for ...
"There are really good anti-osteoporosis medications which are available to keep bones stronger for longer," reassured Mr Jones. "It's never too early to start thinking about your bone health ...
July 24, 2024 — Surgeons compared traditional and new fully hydroxyapatite-coated hip replacement stems. They found the new stems offer larger contact areas, while traditional ones preserve bone ...
According to Indian Menopause Society, around 50 million women in India are affected by osteoporosis, with the risk significantly increasing post-menopause. The menopausal syndrome often manifests ...